Full Press Release Details
Spectral AI Announces
Confirmation of Compliance of its Nasdaq Listing Requirements
DALLAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Spectral
AI (NASDAQ: MDAI) ("Spectral AI" or the "Company"), developer of the AI-driven DeepView System, which
received Breakthrough Device Designation from the U.S.FDA in 2018, that uses multi-spectral imaging and algorithms to predict burn
healing potential, is pleased to announce that on December 20, 2024 the Company received a "moot" letter from Nasdaq
confirming that the Company has regained compliance with all applicable listing standards for its continued listing on the Nasdaq
Capital Market and that a further hearing regarding the Company's compliance is no longer necessary.
"I am thrilled to announce that we
continue to successfully meet our Nasdaq's compliance standards," said Dr. Michael DiMaio, Chairman of Spectral
AI's Board of Directors. "This confirmation reflects our team's hard work and commitment. We are equally excited
about the progress we are making towards our submission to the FDA, as we continue to innovate and strive for excellence in serving
our stakeholders and the medical community."
Spectral AI, Inc. is a Dallas-based predictive
AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications
involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by
"Seeing the Unknown " with its DeepView System. DeepView is a predictive device that offers clinicians an objective and
immediate assessment of a wound's healing potential prior to treatment or other medical intervention. With algorithm-driven
results and a goal of exceeding the current standard of care in the future, DeepView is expected to provide
faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more
information about DeepView, visit www.spectral-ai.com.
statements made in this release are "forward looking statements" within the meaning of the "safe harbor"
provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company's
intention to separate its Spectral IP subsidiary from the Company, and each Company's strategy, plans, objectives,
initiatives, strategic goals, financial outlook or other non-historical matters. When used in this press release, the words
"estimates," "projected," "expects," "anticipates," "forecasts,"
"plans," "intends," "believes," "seeks," "may," "will,"
"should," "future," "propose" and variations of these words or similar expressions (or the
negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking
statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks,
uncertainties, assumptions and other important factors, many of which are outside Company's control, that could cause actual
results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not
to place undue reliance on any forward-looking statements. Investors should carefully consider the foregoing factors and the other
risks and uncertainties described in the "Risk Factors" sections of the Company's filings with the SEC, including
the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks
and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking
statements. Spectral AI undertakes no obligation to update any forward-looking statements except as otherwise required by
and Investor Relations, please contact:
Atlanta Capital Partners LLC
(866) 692-6847 Toll Free - U.S. & Canada
(404) 281-8556 Mobile and WhatsApp